 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              Bombay Stock Exchange has announced that effective from October 19, 2007, the equity shares of Saamya Biotech India Ltd (Scrip Code: 532905) shall listed and admitted to dealings on the Exchange in the list of 'B1' Group Securities.
The company issued shares at a price of Rs.10 Per share (Face Value of Rs. 10/-) in the recently concluded IPO.
The ISIN Code of the company is INE320H01019.
Aarthi Consultants Private Limited is the Registrar to the issue.
DHIREN HASMUKHLAL VORA, PARK LIGHT INVESTMENT PRIVATE LIMITED, DEEP INFRASTRUCTURE PVT. LTD, MR. ASHVIN SOMCHAND SHETH, HARSHA RAJESH JHAVERI, VICKY R JHAVERI, PARMANAND GANPATRAM KHANDWALA, ELEGANT PROJECTS PVT LTD and RUPESH BALVANTBHAI BRAHMBHATT are the major shareholders of the company under Public Category.